http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : ( Issa Nazarov ) (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
Laparoscopic Management of a Cystic Duct Cyst
( Issa Nazarov ),( Ilyas Nazarov ) 대한간학회 2020 춘·추계 학술대회 (KASL) Vol.2020 No.1
Aims: Choledochal cysts are rare cystic dilatations of the biliary tree. These cysts are usually referred for surgical resection because of their association with developing malignancy. We describe one rare case of a cyst of the cystic duct that we successfully treated via laparoscopic resection. Methods: A 43-year-old male was found to have a biliary abnormality on a routine follow-up computed tomography (CT) scan for an unrelated medical condition. Further magnetic resonance cholangiopancreatography (MRCP) imaging identified a cystic dilation consistent with a Type II choledochal cyst. Results: Laparoscopic resection was performed using a total of 5 trocars, at which time a cyst of the cystic duct was found instead of the expected Type II choledochal cyst. Intraoperative cholangiography was used as a surgical adjunct to confirm the anatomy, and resection of the cyst was completed without complications. Conclusions: Our case adds to the body of reports showing that cysts of the cystic duct, while extremely rare, do occur and need to be recognized. Given the preoperative similarity between cystic duct cysts and other choledochal cysts, proposal for a new “Type VI” category for choledochal cysts may be considered so that clinicians can be prepared for this variation. Once recognized, cysts of the cystic duct can be safely and effectively removed by laparoscopic excision, as we have demonstrated.
-
Comparison of Two Transarterial Chemoembolization Strategies for Hepatocellular Carcinoma
( Ilyas Nazarov ),( Issa Nazarov ) 대한간학회 2020 춘·추계 학술대회 (KASL) Vol.2020 No.1
Aims: This retrospective study aimed to compare the efficacy of and tolerance to two center-related conventional transarterial chemoembolization (TACE) strategies in the management of unresectable hepatocellular carcinoma (HCC). Methods: All HCC patients in whom TACE was initiated in the two centers from July 2008 to June 2016 were included. The TACE strategy performed in center 1 was “on demand” with selective injections of idarubicin, whereas the TACE strategy in center 2 was based “on scheduled” non-selective injections of epirubicin. Toxicity was evaluated using the National Cancer Institute Common Terminology Criteria for Adverse Events. Results: One hundred and fifty HCC patients were included. Median time to treatment failure was significantly higher in center 1, 13.1 months vs. 7.9 months in center 2 (hazard ratio, 2.32; P<10-3 in multivariate analysis). Median overall survival was 21.1 months in center 1 vs. 18.4 months in center 2 (P=NS). The proportion of grade ≥ 3 adverse events and mean hospitalisation duration for the overall TACE treatment were significantly greater in center 2 than in center 1: 56% vs. 32% (P<0.01) and 14.2 ± 7.2 days vs. 10.3 ± 7.0 days (P<0.01), respectively. Conclusions: Our results failed to show any significant survival differences between two center-related TACE strategies but showed a significantly smaller proportion of grade ≥ 3 adverse events and shorter hospitalisation for the overall treatment when the “on-demand” strategy was used.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
